While the reduction in influenza cases in the Northern hemisphere in 2020 has been widely reported, the influenza transmission dynamics in the Southern hemisphere remain uncharacterized. This study analysed the change in influenza-positive proportion (IPP) between 2010-2019 and 2020 in countries in the Southern hemisphere with ≤40% missing IPP data in FluNet to assess how coronavirus disease 2019 (COVID-19) relates to influenza activity. The analysis considered the incidence of COVID-19 reported by the World Health Organization and the implementation date of non-pharmaceutical interventions (NPIs) reported by the Oxford COVID-19 Government Response Tracker. In each of the seven included countries, the average IPP was lower in 2020 than in 2010-2019 (P < 0.01), with the largest difference being 31.1% (95% confidence interval 28.4-33.7%). In Argentina, Bolivia, Chile and South Africa, higher IPPs were observed during epidemiological weeks 4-16 in 2020 compared with the same weeks in 2010-2019. The IPP increased after NPIs were implemented in Argentina and South Africa, but started to decline in Bolivia, Chile, Madagascar and Paraguay before NPI implementation. Influenza burden and activity decreased in 2020 in the Southern hemisphere. The temporal decline in influenza activity varied between countries.

Background: This study was performed to investigate the association between body mass index (BMI) and gastric cancer in East and Southeast Asia where most of gastric cancer is non-cardia gastric cancer. Methods: On the basis of 8,997 gastric cancer cases among the Asia Cohort Consortium participants from China, Japan, Korea, and Singapore (N = 538,835), we assessed gastric cancer risk according to BMI by calculating hazard ratios (HR) and 95% confidence intervals (CI) using the Cox proportional hazard regression model. Results: A U-shaped associations between BMI and gastric cancer risk were observed. Gastric cancer risks in underweight group (<18.5 kg/m2) and in obesity group (≥27.5 kg/m2) were higher than reference BMI group (23–24.9 kg/m2; HR, 1.15; 95% CI, 1.05–1.25 for underweight; HR, 1.12; 95% CI, 1.03–1.22 for obesity, respectively). The associations of underweight and obesity with gastric cancer risk were consistent in the analyses for non-cardia gastric cancer, intestinal-type gastric cancer, and late-onset gastric cancer. No significant association of underweight and obesity with the risk of cardia gastric cancer, diffuse-type gastric cancer, and early-onset gastric cancer was observed. In addition, we found that the U-shaped association between BMI and gastric cancer risk remained in nonsmokers, while only underweight was related to increased gastric cancer risk in smokers. Conclusions: BMI has a U-shaped association with gastric cancer risk in East and Southeast Asian population, especially for the non-cardia gastric cancer, intestinal-type gastric cancer, and late-onset gastric cancer. Impact: Future studies with consideration of anatomic location and histology of gastric cancer are needed to establish the association of underweight as well as obesity with gastric cancer risk.

An S, et al. J Korean Med Sci. 2022 May;37(18):e149. https://doi.org/10.3346/jkms.2022.37.e149

Hyeong Ho Jo, Nayoung Kim, Jieun Jang, Yonghoon Choi, Jaehyung Park, Young Mi Park, Soyeon Ahn, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Hyeon Jeong Oh, Hye Seung Lee, Young Suk Park, Sang-Hoon Ahn, Yun-Suhk Suh, Do Joong Park, Hyung Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, and Young Hoon Kim. Gut and Liver 2023;17:243-58. https://doi.org/10.5009/gnl220104

The purpose of this study was to determine the associations between blood hemoglobin (Hgb) levels and the risk of death by specific causes. Using the National Health Insurance Services-National Health Screening Cohort (n=487 643), we classified serum Hgb levels into 6 sex-specific groups. Cox regression analysis was used to analyze the associations between Hgb levels and the risk of cause-specific death. Hgb levels in male population showed a U-shaped, J-shaped, or inverse J-shaped association with the risk of death from ischemic heart disease, acute myocardial infarction, liver cancer, cirrhosis and chronic obstructive pulmonary disease (COPD) (all non-linear p<0.05; hazard ratio [HR]; 95% confidence interval [CI]) for the lowest and the highest Hgb levels for the risk of each cause of death in male population: HR, 1.14; 95% CI, 0.98 to 1.34; HR, 2.87; 95% CI, 1.48 to 5.57; HR, 1.16; 95% CI, 0.96 to 1.40; HR, 3.05; 95% CI, 1.44 to 6.48; HR, 1.36; 95% CI, 1.18 to 1.56; HR, 2.11; 95% CI, 1.05 to 4.26; HR, 3.64; 95% CI, 2.49 to 5.33; HR, 5.97; 95% CI, 1.44 to 24.82; HR, 1.62; 95% CI, 1.14 to 2.30; HR, 3.84; 95% CI, 1.22 to 12.13, respectively), while in female population, high Hgb levels were associated with a lower risk of death from hypertension and a higher risk of death from COPD (overall p<0.05; HR, 1.86; 95% CI, 1.29 to 2.67 for the lowest Hgb levels for hypertension; overall p<0.01, HR, 6.60; 95% CI, 2.37 to 18.14 for the highest Hgb levels for COPD). For the risk of lung cancer death by Hgb levels, a linear negative association was found in male population (overall p<0.01; the lowest Hgb levels, HR, 1.17; 95% CI, 1.05 to 1.33) but an inverse J-shaped association was found in female population (non-linear p=0.01; HR, 1.25; 95% CI, 0.96 to 1.63; HR, 2.58; 95% CI, 1.21 to 5.50). Both low and high Hgb levels were associated with an increased risk of death from various causes, and some diseases showed different patterns according to sex.

Jo HH, et al. J Gastric Cancer. 2025 Feb;25:e17. https://doi.org/10.5230/jgc.2025.25.e17